یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references.
یادداشتهای مربوط به مندرجات
متن يادداشت
I. Introductory essay. 1. Introduction -- 2. Early training and research -- 3. Genetic polymorphism -- 4. The study of transfused patients, 1960 -- 5. The Institute for Cancer Research, Fox Chase Cancer Center, 1964-1997 -- 6. Australia antigen and the hepatitis B virus, 1964 -- 7. Control of post-transfusion hepatitis B, 1969 -- 8. Invention of Hepatitis B Vaccine, 1969 -- 9. HBV and primary cancer of the liver, 1969 -- 10. Iron and iron-binding proteins, 1974 -- 11. HBV, genetics, and related topics, 1967 -- 12. Methods of transmission -- 13. Anti-virals -- 14. Miscellaneous, ephemeral, and unpublished articles -- 15. Hepatitis B virus; a subjective view -- II. Selected publications: bibliography -- III. Facsimiles of selected publications -- IV. Acknowledgements.
بدون عنوان
0
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
This important book comprises a narrative account of research on the hepatitis B virus (and related subjects) and selected reprints from the laboratory of Nobel laureate Baruch S Blumberg and his colleagues. The hepatitis B virus (HBV) is one of the ten most common deadly infectious diseases and is responsible for 1.1 million deaths a year worldwide. Research in his laboratory resulted in the discovery of HBV and the invention of the vaccine which protects one against it. The research began as an apparently esoteric study of human biochemical and immunologic variation. This required field-work in Africa, the Arctic, the Pacific, the Americas, and in many other locations and populations. The overall goal was to identify inherited biological differences which were related to differing responses to disease-causing agents. The virus was discovered using the blood of an infected person who had developed the antibody, to detect the virus present in another infected person who had become a carrier of the virus. Screening of blood donors led to the near-elimination of post-transfusion hepatitis B. There are now national HBV vaccination programs in more than 70 countries. During the past decade these programs have strikingly reduced the prevalence of HBV in many countries and there has been a significant drop in the incidence of cancer of the liver in the vaccinated cohorts. The HBV vaccination program is now, after smoking cessation, the most widely used cancer prevention program in the world.
ویراست دیگر از اثر در قالب دیگر رسانه
عنوان
Hepatitis B and the prevention of primary cancer of the liver.
شماره استاندارد بين المللي کتاب و موسيقي
9789810232177
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Hepatitis B.
موضوع مستند نشده
Liver-- Cancer-- Prevention.
موضوع مستند نشده
Genetic Predisposition to Disease.
موضوع مستند نشده
Hepatitis B-- prevention & control.
موضوع مستند نشده
Hepatitis B Vaccines.
موضوع مستند نشده
Liver Neoplasms-- prevention & control.
موضوع مستند نشده
Polymorphism, Genetic.
موضوع مستند نشده
Bibliografie
موضوع مستند نشده
Hepatitis B
موضوع مستند نشده
Hepatitis B.
موضوع مستند نشده
Leberkrebs
موضوع مستند نشده
Liver-- Cancer-- Prevention.
موضوع مستند نشده
MEDICAL-- Hepatology.
موضوع مستند نشده
Prävention
مقوله موضوعی
موضوع مستند نشده
MED-- 114000
رده بندی ديویی
شماره
616
.
3/623
ويراست
22
رده بندی کنگره
شماره رده
RC848
.
H44
نشانه اثر
H4835
2000eb
سایر رده بندی ها
شماره رده
YC
5609
شماره رده
W1
شماره رده
WC
536
نشانه اثر
WO898L
v
.
4
2000
نشانه اثر
B658h
2000
کد سيستم
rvk
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )